Neeraj Agarwal: Statins Linked to Better Survival in Advanced Prostate Cancer
Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post on X about a paper he co-authored with colleagues published in JAMA Network Open:
”Just in JAMA Network Open.
In patient-level data from two phase 3 trials (n = 2,187), statin use was associated with increased overall survival in advanced prostate cancer treated with apalutamide.
Congratulations to Zeynep Irem Ozay and Soumyajit Roy.”
Petros Grivas, Clinical Director of the GU cancers Program at the University of Washington, shared this post, adding:
“Congrats, Zeynep Irem Ozay, Neeraj Agarwal, and everyone else! Very interesting paper.”
Title: Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Authors: Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, Yilun Sun, Kim N. Chi, Scott C. Morgan, Shawn Malone, Christopher J. D. Wallis, Jason R. Brown, Pedro C. Barata, Amar U. Kishan, Angela Y. Jia, Nicholas G. Zaorsky, Umang Swami, Simon Chowdhury, Eric J. Small, Daniel E. Spratt, Fred Saad, Neeraj Agarwal
You can read the Full Article on JAMA Network Open.
More posts featuring Neeraj Agarwal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023